serum; plasma exosomes; HCC tissues; lung metastatic nodules
L02; Hep3B; HLE; Huh7; BEL7402; SMMC7721; MHCC97L; MHCC97H; HCCLM3; HCCLM6; HUVEC
cell line-derived xenograft
angiogenesis (promotes); proliferation (promotes); invasion (promotes); metastasis (promotes); other pathway/process (promotes)
RT-qPCR; Transfection; Transwell Assay; MTT; Tube Formation Assay; RNA Pull-Down; Western Blot; ELISA; In Vivo Animal Model; IHC (Immunohistochemistry); H&E Staining; Survival Analysis; Bioinformatics Analysis
Persistent high expression of serum exosomal circRNA-100,338 after curative hepatectomy may indicate pulmonary metastasis risk and poor survival; Post/Pre ratio used as prognostic indicator
Exosomal circRNA-100,338 is up-regulated in highly metastatic HCC cells and their exosomes and promotes HCC invasion and metastasis. After transfer to recipient HUVECs, it enhances endothelial proliferation, angiogenesis, permeability and VM formation, partly associated with altered VE-Cadherin/ZO-1 and increased MMP9, and it binds multiple proteins (including NOVA2). Serum exosomal circRNA-100,338 dynamics after hepatectomy are associated with pulmonary metastasis risk and poorer survival.
0.7132
Exosomal circRNA-100338 promotes hepatocellular carcinoma metastasis via enhancing invasiveness and angiogenesis.
combined biological and clinical study